*To be consumed as directed by physician.
Therapies:
Hepatitis
Composition:
Daclatasvir (60 mg)
Daclahep 60 mg Tablets contains daclatasvir, an antiviral agent specifically targeting Hepatitis C virus (HCV). It is used in combination with sofosbuvir to treat chronic HCV genotype 3 infections. Daclatasvir works by inhibiting the HCV NS5A protein, preventing the virus from replicating and supporting the body's immune response. While it controls the infection, Daclahep is not a cure for HCV and is not intended for preventing HCV infection. For optimal results, it must be taken as prescribed, alongside other antiviral medications. Proper adherence to the dosage schedule increases treatment effectiveness.
*To be consumed as directed by physician.